Oregon moves ahead on legal psychedelic therapy rules

In Politics by Michael Rae

In 2020, Oregon voters approved Measure 109, the ballot initiative which directs the Oregon Health Authority to establish a regulated market for psilocybin treatments.  Like marijuana, psilocybin is a Schedule I substance under the federal Controlled Substances Act. Thus, the substance is banned and the federal government officially recognizes no medical benefits from its use.  Also, like marijuana, a plethora of medical research has emerged revealing psilocybin’s substantial potential benefits regardless of federal bureaucrats’ official position.

Oregon, however, is poised to challenge federal hegemony on drug-related commerce that occurs within its own borders, just as it has done with marijuana.  The

Read more at Reason.org